Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$535K Sell
670
-1,202
-64% -$800K ﹤0.01% 882
2026
Q1
$1.02M Sell
1,872
-4,278
-70% -$1.74M 0.01% 583
2025
Q4
$1.93M Buy
+6,150
New +$1.95M 0.02% 444
2025
Q3
Sell
-3,722
Closed -$821K 1051
2025
Q2
$821K Buy
+3,722
New +$671K 0.01% 707
2025
Q1
Sell
-3,162
Closed -$433K 1509
2024
Q4
$433K Sell
3,162
-3,710
-54% -$510K 0.01% 909
2024
Q3
$697K Buy
6,872
+583
+9% +$46.1K 0.01% 1041
2024
Q2
$460K Buy
+6,289
New +$412K 0.01% 1208
2021
Q4
Sell
-3,624
Closed -$536K 1157
2021
Q3
$536K Buy
+3,624
New +$164K 0.03% 589

Other funds holding AGX

Centiva Capital's AGX Position: Q2 2026 in Review

Centiva Capital reduced its Argan (AGX) stake by 64% in Q2 2026, selling an estimated $800K and leaving 670 shares worth $535K. The position accounts for ﹤0.01% of the portfolio, ranked #882.

Centiva Capital first reported a position in AGX in Q3 2021 and has held it in 8 quarters since. The position peaked at $1.93M in Q4 2025. 563 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

  • Centiva Capital held 670 shares of Argan worth $535K as of Q2 2026.
  • Centiva Capital sold 1,202 Argan shares in Q2 2026, an estimated $800K.
  • Argan made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #882 holding.
  • Centiva Capital first reported a position in Argan in Q3 2021 and has held it in 8 quarters since.
  • Centiva Capital's Argan position peaked at $1.93M in Q4 2025.
  • 563 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.